Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Samulski

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Experimental Neurology|March 19, 2008
AAV2-mediated gene transfer of GDNF to the striatum of MPTP monkeys enhances the survival and outgrowth of co-implanted fetal dopamine neuronsJ D Elsworth, D E Redmond, C Leranth, et al.
Gene Therapy|March 29, 2013
Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapyA-M Lompré, L Hadri, E Merlet, et al.
Gene Therapy|September 25, 1998
In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vectorM J During, R J Samulski, J D Elsworth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological NanoparticlesWuping Li, Aravind Asokan, Zhijian Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2008
Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticlesWuping Li, Aravind Asokan, Zhijian Wu, et al.
The Journal of Gene Medicine|June 10, 2005
Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiencyUlrich T Hacker, Lisa Wingenfeld, David M Kofler, et al.
Human Gene Therapy|March 12, 2005
Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectorsSifeng Chen, Matthias Kapturczak, Scott A Loiler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2011
Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vectorDawn E Bowles, Scott W J McPhee, Chengwen Li, et al.
Human Gene Therapy|November 25, 2014
Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trialPaul E Monahan, Junjiang Sun, Tong Gui, et al.
European Journal of Heart Failure|April 9, 2026
AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: Rationale and study design of the GenePHIT trialT D Henry, E S Chung, M Alvisi, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Experimental Neurology|March 19, 2008
AAV2-mediated gene transfer of GDNF to the striatum of MPTP monkeys enhances the survival and outgrowth of co-implanted fetal dopamine neuronsJ D Elsworth, D E Redmond, C Leranth, et al.
Gene Therapy|March 29, 2013
Efficient transduction of vascular smooth muscle cells with a translational AAV2.5 vector: a new perspective for in-stent restenosis gene therapyA-M Lompré, L Hadri, E Merlet, et al.
Gene Therapy|September 25, 1998
In vivo expression of therapeutic human genes for dopamine production in the caudates of MPTP-treated monkeys using an AAV vectorM J During, R J Samulski, J D Elsworth, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 9, 2017
Engineering and Selection of Shuffled AAV Genomes: A New Strategy for Producing Targeted Biological NanoparticlesWuping Li, Aravind Asokan, Zhijian Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 27, 2008
Engineering and selection of shuffled AAV genomes: a new strategy for producing targeted biological nanoparticlesWuping Li, Aravind Asokan, Zhijian Wu, et al.
The Journal of Gene Medicine|June 10, 2005
Adeno-associated virus serotypes 1 to 5 mediated tumor cell directed gene transfer and improvement of transduction efficiencyUlrich T Hacker, Lisa Wingenfeld, David M Kofler, et al.
Human Gene Therapy|March 12, 2005
Efficient transduction of vascular endothelial cells with recombinant adeno-associated virus serotype 1 and 5 vectorsSifeng Chen, Matthias Kapturczak, Scott A Loiler, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 10, 2011
Phase 1 gene therapy for Duchenne muscular dystrophy using a translational optimized AAV vectorDawn E Bowles, Scott W J McPhee, Chengwen Li, et al.
Human Gene Therapy|November 25, 2014
Employing a gain-of-function factor IX variant R338L to advance the efficacy and safety of hemophilia B human gene therapy: preclinical evaluation supporting an ongoing adeno-associated virus clinical trialPaul E Monahan, Junjiang Sun, Tong Gui, et al.
European Journal of Heart Failure|April 9, 2026
AB-1002 gene therapy expressing active protein phosphatase inhibitor-1 in heart failure: Rationale and study design of the GenePHIT trialT D Henry, E S Chung, M Alvisi, et al.
Pageof 13